Champions Oncology, Inc. CSBR Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Champions Oncology, Inc. CSBR Company Overview 

Stock Message Board http://investorshangout.com/search?q=CSBR&...mp;yt1=Go!

Champions Oncology, Inc. CSBR Current Price and Quotes
Last Price 1.78
Previous Close 1.75 Open 1.75
Daily Range 1.78 - 1.75 52wk Range 1.99 - 0.21
Volume 4,800 Dividend N/A
Average Vol (3m) 60,859 Yield N/A
Champions Oncology, Inc. CSBR
Company Information

One University Plaza
Suite 307
Hackensack, NJ 07601

Website: http://www.championsoncology.com
Phone: 201-808-8400
Email: info@championsoncology.com

Champions Oncology, Inc. CSBR
Champions Oncology, Inc. CSBR
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jul 31, 2013 10-Q
CIK 0000771856
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Joel Ackerman CEO
Ronnie Morris President
Gary G. Gemignani EVP, CFO
Susan Foreman IR
Company Directors

Scott R. Tobin
Company Notes

Formerly=Champions Biotechnology, Inc. until 4-2011
Formerly=Champions Sports, Inc. until 2-07
Formerly=International Group, Inc. to 2-86
Service Providers

Auditor/Accountant
Ernst & Young LLP
250 South Australian Avenue
Suite 900
West Palm Beach, FL, 33401
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Champions Oncology, Inc. CSBR
CSBR Security Details

Share Structure

Market Value1 $118,996,738 a/o Sep 20, 2013
Shares Outstanding 66,852,100 a/o Aug 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 2,139 a/o Jul 26, 2013
Security Notes

New Issue=8-85 40,000,000 shs in units (1 sh Com & 1 Warr 11-8-86) at 1 cent per unit (best efforts-30,000,000 min.) by the company
Par Changed=10-31-91 $0.00001 to $0.001 Basis: 1 for 100 reverse split
Short Selling Data

Short Interest 1,800 (100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Integrity Stock Transfer

Champions Oncology, Inc. CSBR Recent News

Sept 13, 2013 UPDATE -- Champions Oncology Reports Results for the Quarter Ended July 31, 2013
Sept 13, 2013 Champions Oncology Reports Results for the Quarter Ended July 31, 2013
Sept 13, 2013 Champions Oncology and Teva Sign a Discovery and Drug Development Partnership
Sept 10, 2013 Champions Oncology Receives Regulatory Approval From New York State Department of Health
Sept 10, 2013 Champions Oncology to Announce First Quarter Financial Results on Friday, September 13
Sept 4, 2013 Champions Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference
Sept 3, 2013 OtcbbJournal.com Initiates Coverage on ETAH, CSBR, AIVN and MTPR
Sept 3, 2013 Champions Oncology Announces Two Additions to Senior Management Team
Aug 16, 2013 OTC Daily Alert Stock Watch - Champions Oncology, Inc (OTCQB: CSBR)


Champions Oncology, Inc. CSBR Financials
Period Ending Apr 30, 2013 Apr 30, 2012 Apr 30, 2011 Apr 30, 2010
Total Revenue 8,323 7,149 6,882 4,893
Cost of Revenue 5,328 4,899 3,511 1,915
Gross Profit 2,995 2,250 3,371 2,978
Operating Expenses

Research and Development 1,920 2,937 2,910 2,622
Sales, General and Admin. 7,296 8,378 5,696 3,284
Non-Recurring Items - - - -
Other - - - -
Operating Income (6,221) (9,065) (5,235) (2,928)
Income From Continuing Operations

Add'l Income/Expense Items (99) 402 1,444 5
Earnings Before Interest and Tax (6,320) (8,663) (3,791) (2,923)
Interest Expense - - - -
Earnings Before Tax (6,320) (8,663) (3,791) (2,923)
Income Tax 10 (2) 11 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (6,330) (8,661) (3,802) (2,923)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (6,330) (8,661) (3,802) (2,923)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (6,330) (8,661) (3,802) (2,923)

CSBR Champions Oncology, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CSBR&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CSBR/quote
Stock Chart http://www.otcmarkets.com/stock/CSBR/chart
Company Info http://www.otcmarkets.com/stock/CSBR/company-info
Recent News http://www.otcmarkets.com/stock/CSBR/news
Financials http://www.otcmarkets.com/stock/CSBR/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CSBR/filings
Short Sales http://www.otcmarkets.com/stock/CSBR/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CSBR/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CSBR/research
Summary http://finance.yahoo.com/q?s=CSBR
Historical Prices http://finance.yahoo.com/q/hp?s=CSBR+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CSBR
Basic Chart http://finance.yahoo.com/q/bc?s=CSBR+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CSBR+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CSBR+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CSBR+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CSBR+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CSBR+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CSBR+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CSBR+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CSBR+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CSBR+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CSBR
Balance Sheet http://finance.yahoo.com/q/bs?s=CSBR
Cash Flow http://finance.yahoo.com/q/cf?s=CSBR+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CSBR
Market Watch http://www.marketwatch.com/investing/stock/CSBR
Bloomberg http://www.bloomberg.com/quote/CSBR:US
Morningstar http://quotes.morningstar.com/stock/s?t=CSBR
Bussinessweek http://investing.businessweek.com/research/st...icker=CSBR
Barchart http://www.barchart.com/quotes/stocks/CSBR
OTC Short Report http://otcshortreport.com/index.php?index=CSBR
Investopedia http://www.investopedia.com/markets/stocks/CSBR/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 382

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 298

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 700

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Carter's P/E Ratio: Investor Insights Revealed

Updated Category News Views 189

Carter's Inc.: Analyzing the Current P/E Ratio Carter's Inc. (CRI) is currently trading at $23.70, observing a drop of 2.23% in its latest session. Over the preceding month, the stock has seen a significant decline of 24.72%, and an even steeper fall of 60.12% within the last year. This decline prompts long-term shareholders and potential investors to evaluate the...

Continue Reading
Planet Green Welcomes Dr. Raymond Goldie to Advisory Board

Updated Category News Views 170

Planet Green Welcomes Dr. Raymond Goldie to Its Advisory Board Planet Green Metals Inc. (CSE: PGR) is excited to announce that Dr. Raymond Goldie has officially joined the Company’s Advisory Board. Introducing Dr. Raymond Goldie Dr. Goldie currently serves as the President of the Prospectors and Developers Association of Canada. He is well-known for his engaging...

Continue Reading
Mabwell Showcases 7MW4811's Promising Pre-clinical Results

Updated Category News Views 136

Mabwell Unveils Exciting Pre-clinical Findings of 7MW4811 Mabwell (688062.SH) is an innovative biopharmaceutical company known for its efforts to revolutionize cancer treatment. Recently, Mabwell presented a compelling poster on the "Preclinical Development of 7MW4811, an Mtoxin™ (MF6)-based Antibody-drug Conjugate for the Treatment of Solid Tumors" at the esteemed...

Continue Reading
Apple's Juno App Removal Sparks Developer's Reaction

Updated Category News Views 216

Apple Takes Action Against Unofficial YouTube App for Vision Pro Recently, Apple Inc. (NASDAQ: AAPL) made the decision to remove Juno, an unofficial YouTube application crafted for the Vision Pro headset, from its App Store. This move follows a formal warning from Google, part of Alphabet Inc. (NASDAQ: GOOG) and GOOGL), emphasizing compliance with YouTube's guidelines....

Continue Reading
Understanding the Wayne Memorial Hospital Data Breach

Updated Category News Views 233

Overview of the Data Breach Incident In recent news, Wayne Memorial Hospital has disclosed a significant data breach that has affected a large number of individuals. This hospital, well-known for providing a wide array of medical services, encountered a cybersecurity incident that compromised a vast range of sensitive personal information. The hack involved unauthorized...

Continue Reading